Literature DB >> 15799052

23Na MRI combined with contrast-enhanced 1H MRI provides in vivo characterization of infarct healing.

Hanns B Hillenbrand1, Lewis C Becker, Reza Kharrazian, Kai Hu, Carlos E Rochitte, Raymond J Kim, Enn L Chen, Georg Ertl, Ralph H Hruban, João A C Lima.   

Abstract

Although (23)Na MRI has been shown to delineate acute myocardial infarction (MI), the time course of in vivo (23)Na MRI during infarct healing remains unknown. In this study (23)Na MRI was combined with contrast-enhanced (CE) (1)H MRI to noninvasively characterize infarct healing in vivo. Serial in vivo 3D (23)Na MRI and (1)H MRI were performed for up to 9 weeks postinfarction in 10 dogs. Radioactive microspheres were used to measure myocardial perfusion, and Hematoxylin-Eosin (H&E) and Masson's trichrome (MT) staining were used to assess interstitial cell infiltrate and collagen content. In vivo (23)Na MRI accurately delineated infarct size up to day 5 postinfarction in comparison with (1)H MRI (8.9% +/- 8.1% vs. 8.6% +/- 7.9% on day 1 postinfarction, P = NS; and 6.3% +/- 6.2% vs. 6.2% +/- 6.2% on days 4/5 postinfarction, P = NS). The in vivo (23)Na MRI signal intensity, expressed as the signal intensity ratio of infarcted tissue vs. noninfarcted tissue (MI/R) peaked on day 1 of infarction (2.04 +/- 0.23) but decreased significantly to 1.27 at 9 weeks postinfarction (P < 0.05) due to granulation tissue infiltrate and collagen deposition. To confirm the MI/R decrease during scar formation ex vivo, we performed (23)Na MRI in 12 rats on day 3 post-MI (N = 5) and after 6 weeks (N = 7). H&E and Picrosirius Red staining confirmed granulation tissue infiltrate on day 3 and scar formation after 6 weeks. MI/R decreased significantly from 1.91 +/- 0.45 on day 3 post-MI to 1.3 +/- 0.09 after 6 weeks. Thus, in vivo (23)Na MRI accurately delineates infarct size up to day 5 postinfarction. In vivo (23)Na MRI signal intensity decreases during infarct healing as a result of the underlying infarct healing process. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799052     DOI: 10.1002/mrm.20417

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  3 in total

1.  Advances in Magnetic Resonance Imaging for the assessment of degenerative disc disease of the lumbar spine.

Authors:  Chenyang Wang; Joshua D Auerbach; Walter R T Witschey; Richard A Balderston; Ravinder Reddy; Arijit Borthakur
Journal:  Semin Spine Surg       Date:  2007-06

2.  Differentiation of acute and four-week old myocardial infarct with Gd(ABE-DTTA)-enhanced CMR.

Authors:  Robert Kirschner; Levente Toth; Akos Varga-Szemes; Tamas Simor; Pal Suranyi; Pal Kiss; Balazs Ruzsics; Attila Toth; Robert Baker; Brigitta C Brott; Silvio Litovsky; Ada Elgavish; Gabriel A Elgavish
Journal:  J Cardiovasc Magn Reson       Date:  2010-04-07       Impact factor: 5.364

3.  Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro.

Authors:  Elizabeth Kehr; Megan Sono; Sumeet S Chugh; Michael Jerosch-Herold
Journal:  Int J Cardiovasc Imaging       Date:  2007-04-12       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.